Hedge Fund - Rhenman & Partners Asset Management
Cvs Health Corp (CVS)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $15,979,651 | 1.84% | 235,862 | $59.84 |
2 | 2024 - Q4 (2024-12-31) | $12,008,075 | 1.23% | 267,500 | $56.10 |
3 | 2024 - Q3 (2024-09-30) | $11,569,920 | 0.93% | 184,000 | $58.34 |
4 | 2024 - Q1 (2024-03-31) | $0 | 0% | 0 | $76.39 |
5 | 2023 - Q4 (2023-12-31) | $10,857,000 | 1.08% | 137,500 | $71.17 |
6 | 2023 - Q3 (2023-09-30) | $20,946,000 | 2.25% | 300,000 | $70.86 |
7 | 2023 - Q2 (2023-06-30) | $17,144,240 | 1.8% | 248,000 | $71.15 |
8 | 2023 - Q1 (2023-03-31) | $12,923,100 | 1.41% | 173,000 | $83.86 |
9 | 2022 - Q4 (2022-12-31) | $15,935,490 | 1.66% | 171,000 | $96.49 |
10 | 2022 - Q3 (2022-09-30) | $21,308,000 | 2.23% | 225,000 | $98.99 |
11 | 2022 - Q2 (2022-06-30) | $26,871,000 | 3.05% | 290,000 | $97.60 |
12 | 2022 - Q1 (2022-03-31) | $23,784,000 | 2.34% | 235,000 | $105.05 |
13 | 2021 - Q4 (2021-12-31) | $42,509,000 | 2.82% | 410,000 | $92.41 |
14 | 2021 - Q3 (2021-09-30) | $33,944,000 | 2.38% | 400,000 | $83.76 |
15 | 2021 - Q2 (2021-06-30) | $31,707,000 | 2.15% | 380,000 | $81.89 |
16 | 2021 - Q1 (2021-03-31) | $33,854,000 | 2.36% | 450,000 | $72.84 |
17 | 2020 - Q4 (2020-12-31) | $28,686,000 | 2.34% | 420,000 | $65.04 |
18 | 2020 - Q3 (2020-09-30) | $14,016,000 | 1.24% | 240,000 | $62.22 |
19 | 2020 - Q2 (2020-06-30) | $14,748,000 | 1.59% | 227,000 | $62.97 |
20 | 2020 - Q1 (2020-03-31) | $15,426,000 | 2.16% | 260,000 | $66.76 |
21 | 2019 - Q4 (2019-12-31) | $10,416,000 | 1.14% | 140,214 | $70.22 |
22 | 2019 - Q3 (2019-09-30) | $19,159,000 | 2.4% | 303,768 | $59.26 |
23 | 2019 - Q2 (2019-06-30) | $18,732,000 | 2.06% | 343,768 | $53.85 |
24 | 2018 - Q4 (2018-12-31) | $26,789,000 | 3.06% | 408,868 | $74.65 |
25 | 2018 - Q3 (2018-09-30) | $34,548,000 | 3.46% | 438,868 | $71.49 |
26 | 2018 - Q2 (2018-06-30) | $24,058,000 | 2.46% | 373,868 | $65.90 |
27 | 2018 - Q1 (2018-03-31) | $15,793,000 | 1.94% | 253,868 | $71.75 |
28 | 2017 - Q4 (2017-12-31) | $0 | 0% | 0 | $72.70 |
29 | 2017 - Q3 (2017-09-30) | $9,758,000 | 1.24% | 120,000 | $79.10 |
30 | 2017 - Q2 (2017-06-30) | $6,839,000 | 0.98% | 85,000 | $78.96 |
31 | 2017 - Q1 (2017-03-31) | $10,205,000 | 1.61% | 130,000 | $79.83 |
32 | 2016 - Q4 (2016-12-31) | $11,047,000 | 2.11% | 140,000 | $80.91 |
33 | 2016 - Q3 (2016-09-30) | $14,238,400,000 | 2.26% | 160,000 | $94.39 |
34 | 2016 - Q2 (2016-06-30) | $11,489,000 | 2.04% | 120,000 | $99.66 |
35 | 2016 - Q1 (2016-03-31) | $10,892,000 | 2.16% | 105,000 | $97.23 |
36 | 2015 - Q4 (2015-12-31) | $17,599,000 | 2.66% | 180,000 | $97.94 |
The displayed share prices are average quarterly stock market prices.